Vijay K Singh Selected Research

Radiotherapy

1/2021	Changes in the gut microbiome community of nonhuman primates following radiation injury.
1/2021	Radiation exposure induces cross-species temporal metabolic changes that are mitigated in mice by amifostine.
5/2020	BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure.
1/2014	New approaches to radiation protection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vijay K Singh Research Topics

Disease

31	Acute Radiation Syndrome 04/2022 - 01/2012
21	Radiation Injuries (Radiation Sickness) 10/2022 - 04/2005
7	Neoplasms (Cancer) 01/2021 - 08/2006
7	Wounds and Injuries (Trauma) 01/2021 - 05/2013
6	Infections 12/2021 - 01/2005
5	Inflammation (Inflammations) 01/2022 - 08/2008
3	Eales disease 01/2011 - 05/2009
2	Burns 12/2021 - 01/2021
2	Neutropenia 01/2015 - 08/2006
2	Necrosis 05/2012 - 09/2011
2	Body Weight (Weight, Body) 09/2011 - 09/2009
2	Hypoxia (Hypoxemia) 09/2009 - 10/2008
2	Anorexia 06/2005 - 01/2004
1	Starvation 09/2021
1	COVID-19 01/2021
1	Pseudomonas Infections 01/2021
1	Poisoning 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018
1	Parasitic Diseases (Parasitic Disease) 01/2017
1	Vomiting 01/2017
1	Leishmaniasis 01/2017
1	Chickenpox 04/2016
1	Sepsis (Septicemia) 01/2015
1	Anemia 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Cytopenia 05/2012

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 01/2022 - 05/2012
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2016
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2016 - 01/2010
5	Amifostine (Ethyol)FDA LinkGeneric 01/2021 - 12/2016
5	CytokinesIBA 01/2021 - 04/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 04/2005
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
4	alpha-Tocopherol FDA Link 02/2015 - 08/2006
3	pegfilgrastim (Neulasta)FDA Link 12/2017 - 03/2016
3	Filgrastim (Neupogen)FDA Link 12/2017 - 03/2016
3	Interleukin-10 (Interleukin 10)IBA 05/2012 - 04/2004
3	Retinaldehyde (Retinal)IBA 01/2011 - 09/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 05/2009
3	LeptinIBA 09/2009 - 01/2004
2	plastochromanol 8IBA 04/2022 - 01/2016
2	CBLB502IBA 01/2021 - 01/2015
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2017
2	Investigational DrugsIBA 05/2020 - 01/2017
2	GenisteinIBA 03/2019 - 11/2009
2	AntibodiesIBA 10/2018 - 04/2016
2	tocolIBA 01/2016 - 11/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2015 - 05/2012
2	Chemokine ReceptorsIBA 11/2014 - 06/2014
2	SteroidsIBA 11/2012 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 05/2012 - 05/2009
2	Therapeutic UsesIBA 07/2009 - 08/2008
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 07/2009 - 08/2008
1	romiplostim FDA Link 03/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	beta-Lactamases (beta-Lactamase)IBA 12/2021
1	NitrogenIBA 09/2021
1	Particulate MatterIBA 01/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021
1	MetalsIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	SolventsIBA 01/2021
1	sodium salt (E)- 4- carboxystyryl- 4- chlorobenzylsulfoneIBA 01/2021
1	Biological ProductsIBA 01/2020
1	IsoflavonesIBA 03/2019
1	Phytoestrogens (Phytoestrogen)IBA 03/2019
1	EpitopesIBA 10/2018
1	Anaplastic Lymphoma KinaseIBA 10/2018
1	AutoantibodiesIBA 10/2018
1	NucleophosminIBA 10/2018
1	TocotrienolsIBA 05/2016
1	Anti-Infective Agents (Microbicides)IBA 01/2015
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2015
1	Toll-Like Receptor 5IBA 01/2015
1	Cobalt-60IBA 01/2015
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2015
1	LigandsIBA 01/2015
1	Immunologic Factors (Immunomodulators)IBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	6,6'-dicorynomycolyl trehaloseIBA 01/2015
1	Levofloxacin (Levaquin)FDA Link 01/2015
1	monophosphoryl lipid AIBA 01/2015
1	plerixafor FDA Link 11/2014
1	10- methoxy- 2- methyl- 7H- pyrido(4,3- c)carbazolium (MMPC)IBA 06/2012
1	Interleukin-12 (IL 12)IBA 05/2012
1	ChemokinesIBA 05/2012
1	Toll-Like Receptor 2IBA 01/2012
1	LipopeptidesIBA 01/2012
1	BilirubinIBA 09/2011
1	Superoxide DismutaseIBA 09/2011
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2011
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 09/2011
1	Glutathione PeroxidaseIBA 09/2011

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2010
4	Radiotherapy 01/2021 - 01/2014
1	Drug Tapering 06/2012